Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › UT › South Jordan › NPI 1376152983
Lab

Sports Drug Testing Laboratory, LLC

Sports Drug Testing Laboratory, LLC was paid $1.06M by Medicaid between Aug 2020 and Sep 2022, across 3 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 98% of everything it billed.

33Billing provider infoSPORTS DRUG TESTING LABORATORY, LLC
SOUTH JORDAN, UT 84095
33aNPI1376152983assigned 07/29/2020
28Total paid$1.06M
24GClaims33,548
24DCodes billed3
24AFirst – last monthAug 2020 – Sep 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in Utah

Rank by total paid#12 of 35
Median peer was paid$385K
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration98% of spending on code U0003 with only 3 total codes billed. Highly concentrated billing profile.
Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20206,873$309K
202120,896$574K
20225,779$175K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 98% 21,606 17,757 $1.03M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.0% 11,727 10,240 $22K
86328 <1% 215 165 $3K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMONTI, KIM (CFO/CAO/TREASURER)